fluvoxamine maleate Fluvoxamine Maleate 50 MG Oral Tablet
1 INDICATIONS AND USAGE Fluvoxamine maleate tablets, USP are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) [1] . 1.1 Obsessive-Compulsive Disorder Fluvoxamine maleate tablets, USP are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD), as defined in DSM-III-R or DSM-IV. The obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. Obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. The efficacy of fluvoxamine maleate tablets, USP was established in four trials in outpatients with OCD: two 10-week trials in adults, one 10-week trial in pediatric patients (ages 8 to 17), and one maintenance trial in adults (see CLINICAL STUDIES [14] ).
Eon Labs, Inc.
ROUND YELLOW E 15
E 15 ROUND YELLOW
Related Pills
dexmethylphenidate hydrochloride capsule extended release
mylan pharmaceuticals inc.
hydroxyzine 10 mg
epic pharma, llc
hydroxyzine 10 mg
epic pharma, llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Fluvoxamine Maleate Tablets, USP, for oral administration, are available as 25 mg off-white, round, biconvex, film-coated, debossed “ E ” over “17” on one side and plain on the other side and supplied as: NDC 0185-0017-01 bottles of 100 50 mg yellow, round, biconvex, film-coated, debossed “ E ” over “27” on one side and bisected on the other side and supplied as: NDC 0185-0027-01 bottles of 100 NDC 0185-0027-05 bottles of 500 100 mg beige, round, biconvex, film-coated, debossed “ E ” over “157” on one side and bisected on the other side and supplied as: NDC 0185-0157-01 bottles of 100 NDC 0185-0157-05 bottles of 500 16.2 Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure, as required. PROTECT FROM LIGHT. PROTECT FROM HIGH HUMIDITY. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.
More pills like ROUND E 15